Trial intelligence / Profile preview

Levamisole in Loa loa microfilaremic patients

NCT04049630Phase 2Completed

Sponsor
Programme National de Lutte contre l'Onchocercose
Start
Jan 2021
Primary completion
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levamisole in loiasis, sponsored by Programme National de Lutte contre l'Onchocercose. Started Jan 2021; status: completed.

02

Drugs

levamisole
03

Conditions

loiasis

Beyond the preview

Go deeper on NCT04049630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04049630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call